David R. Epstein - 12 May 2022 Form 4 Insider Report for Rubius Therapeutics, Inc. (RUBY)

Role
Director
Signature
/s/ Joanne M. Protano, Attorney-in-Fact
Issuer symbol
RUBY
Transactions as of
12 May 2022
Transactions value $
$0
Form type
4
Filing time
13 May 2022, 16:20:22
Previous filing
02 May 2022
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RUBY Stock Option (Right to Buy) Award $0 +500K $0.00 500K 12 May 2022 Common Stock 500K $1.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested at the time of grant.